Contact Us
Drug Search Results
More Filters [+]

BPX-601

Alternative Names: bpx-601, bpx601, bpx 601
Latest Update: 2023-04-20
Latest Update Note: Clinical Trial Update

Product Description

BPX-601, the companyÕs first GoCAR-T¨Êproduct candidate, incorporates iMC, BellicumÕs inducible co-activation domain.ÊBPX-601 is being evaluated as a treatment for pancreatic and prostate tumors expressing prostate stem cell antigen (PSCA). (Sourced from: https://ir.bellicum.com/news-releases/news-release-details/bellicum-reports-fda-lifted-clinical-hold-bpx-601-phase-12)

Mechanisms of Action: CAR-T,PSCA

Novel Mechanism: Yes

Modality: Cell Therapy

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Bellicum
Company Location: HOUSTON TX 77098
Company CEO: Richard A. Fair
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BPX-601

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Prostate Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
BP-012

P2

Suspended

Prostate Cancer

2025-10-01

23%

Recent News Events

Date

Type

Title

03/14/2023

News Article

 Bellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic Alternatives

02/16/2023

News Article

 Bellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers Symposium

01/19/2023

News Article

 Bellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers Symposium

12/11/2022

News Article

 Bellicum Announces Presentation by UNC at ASH 2022 on Potential Abrogation of iC9 CAR T-Cell Toxicities with Rimiducid

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions